|Articles|July 1, 2015
Biologics Development and Manufacturing Trends, Part 1
Eric Langer, Managing partner at BioPlan Associates, speaks with BioPharm International about the results from the 12th annual BioPlan Associates survey, and single use technology adoption.
Advertisement
Eric Langer, Managing Partner at BioPlan Associates, spoke with BioPharm International about the results from the 12th annual BioPlan Associates survey, and single use technology adoption.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Green Chemistry’s Role in Advancing US Chemical Innovation
2
Industry Outlook 2026: Biopharma Industry Confronts Skills Shortage with Strategic Automation (Part 2)
3
Next-Generation Modalities Drive New Antibody Discovery
4
New $82 Million Biopharma Launch Targets Rare Disease Development With AI-Driven Strategy
5